89 related articles for article (PubMed ID: 31312927)
1. Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Caballero JC; Sánchez Barba M; Hernández Sánchez JM; Such E; Janusz K; Sanz G; Cabrero M; Chillón C; Cervera J; Hurtado AM; Jerez A; Calderón Cabrera C; Valcárcel D; Lumbreras E; Abáigar M; López Cadenas F; Hernández Rivas JM; Del Cañizo MC; Díez Campelo M
Ann Hematol; 2019 Sep; 98(9):2151-2162. PubMed ID: 31312927
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Versluis J; Saber W; Tsai HK; Gibson CJ; Dillon LW; Mishra A; McGuirk J; Maziarz RT; Westervelt P; Hegde P; Mukherjee D; Martens MJ; Logan B; Horowitz M; Hourigan CS; Nakamura R; Cutler C; Lindsley RC;
J Clin Oncol; 2023 Oct; 41(28):4497-4510. PubMed ID: 37607457
[TBL] [Abstract][Full Text] [Related]
3. Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis.
Shahzad M; Iqbal Q; Tariq E; Ammad-Ud-Din M; Butt A; Mushtaq AH; Ali F; Chaudhary SG; Anwar I; Gonzalez-Lugo JD; Abdelhakim H; Ahmed N; Hematti P; Singh AK; McGuirk JP; Mushtaq MU
Crit Rev Oncol Hematol; 2024 Apr; 196():104310. PubMed ID: 38423375
[TBL] [Abstract][Full Text] [Related]
4. Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study.
Condorelli A; Frigeni M; Quaresmini G; Salmoiraghi S; Pavoni C; Grassi A; Raviglione M; Civini A; Putelli A; Lussana F; Finazzi MC; Algarotti A; Micò MC; Spinelli O; Rambaldi A
Leuk Res; 2024 Jul; 142():107529. PubMed ID: 38820666
[TBL] [Abstract][Full Text] [Related]
5. Donor germ-line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes.
Auer PL; Farazi M; Zhang T; Dong J; Bolon YT; Spellman SR; Saber W
Am J Hematol; 2024 Apr; 99(4):770-773. PubMed ID: 38339773
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Caballero JC; Dávila J; López-Pavía M; Such E; Bernal T; Ramos F; Calabuig M; Hernández Sánchez JM; Pomares H; Sánchez Barba M; Abáigar M; González B; Merchán B; Sancho-Tello R; Callejas M; Muñoz-Novas C; Cerveró C; Sanz G; Hernández Rivas JM; Díez Campelo M
Ther Adv Hematol; 2024; 15():20406207231218157. PubMed ID: 38186638
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study.
Zhang T; Auer P; Dong J; Cutler C; Dezern AE; Gadalla SM; Deeg HJ; Nazha A; Carlson KS; Spellman S; Bolon YT; Saber W
J Hematol Oncol; 2023 Apr; 16(1):37. PubMed ID: 37041565
[TBL] [Abstract][Full Text] [Related]
8. [Outcome of allogeneic hematopoietic stem cell transplantation in 14 patients with NPM1-mutated myelodysplastic syndromes].
Wang Y; Chen J; Xue SL; Han Y; Tang XW; Qiu HY; Wu DP; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):66-69. PubMed ID: 36987726
[No Abstract] [Full Text] [Related]
9. Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.
Lehman JS; Hashmi SK; Lazarus HM; El-Azhary RA; Gibson LE; Hogan WJ; Litzow MR; Patnaik MS; Buadi F; Lacy MQ; Dasari S; Vanderboom P; Meves A
J Cutan Pathol; 2017 Dec; 44(12):1087-1091. PubMed ID: 28906023
[No Abstract] [Full Text] [Related]
10. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Myelodysplastic Neoplasm with Complex Karyotype and
Almeida Antônio de Kós E; Lamim Lovatel V; de Cássia Barbosa Tavares R; Moura Ferreira G; Gomes B; Silva Bueno AP; Sobral da Costa E; de Souza Fernandez T
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024040. PubMed ID: 38882450
[No Abstract] [Full Text] [Related]
11. Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
Jiang L; Luo Y; Zhu S; Wang L; Ma L; Zhang H; Shen C; Yang W; Ren Y; Zhou X; Mei C; Ye L; Xu W; Yang H; Lu C; Jin J; Tong H
Cancer Sci; 2020 Feb; 111(2):580-591. PubMed ID: 31804030
[TBL] [Abstract][Full Text] [Related]
12. Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
Huls G; Chitu DA; Pabst T; Klein SK; Stussi G; Griskevicius L; Valk PJM; Cloos J; van de Loosdrecht AA; Breems D; van Lammeren-Venema D; van Zeventer I; Boersma R; Jongen-Lavrencic M; Fehr M; Hoogendoorn M; Manz MG; Söhne M; van Marwijk Kooy R; Deeren D; van der Poel MWM; Legdeur MC; Tick L; Chalandon Y; Ammatuna E; Blum S; Löwenberg B; Ossenkoppele GJ
Blood Adv; 2020 Sep; 4(18):4267-4277. PubMed ID: 32915972
[TBL] [Abstract][Full Text] [Related]
13. High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG).
Salmoiraghi S; Cavagna R; Zanghì P; Pavoni C; Michelato A; Buklijas K; Elidi L; Intermesoli T; Lussana F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Audisio E; Terruzzi E; De Paoli L; Borlenghi E; Cavattoni I; Mattei D; Scattolin A; Tajana M; Ciceri F; Todisco E; Campiotti L; Corradini P; Fracchiolla N; Bassan R; Rambaldi A; Spinelli O
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32796597
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population.
Du MY; Xu M; Deng J; Liu L; Guo T; Xia LH; Hu Y; Mei H
J Cancer; 2020; 11(2):508-519. PubMed ID: 31897246
[TBL] [Abstract][Full Text] [Related]
16. Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms.
Cao YG; He Y; Zhang SD; Liu ZX; Zhai WH; Ma QL; Pang AM; Wei JL; Yang DL; Huang Y; Feng SZ; Jiang EL; Han MZ
Biol Blood Marrow Transplant; 2020 Feb; 26(2):285-291. PubMed ID: 31494229
[TBL] [Abstract][Full Text] [Related]
17. Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR.
Salvati M; Bruzzaniti P; Relucenti M; Nizzola M; Familiari P; Giugliano M; Scafa AK; Galletta S; Li X; Chen R; Barbaranelli C; Frati A; Santoro A
Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32050461
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
Ren Y; Wang J; Zhang H; Mei C; Ye L; Luo Y; Zhou X; Zhu S; Jiang L; Wang L; Jin J; Tong H
Asia Pac J Clin Oncol; 2020 Jun; 16(3):172-179. PubMed ID: 32030889
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia.
Cheng Z; Dai Y; Zeng T; Liu Y; Cui L; Qian T; Si C; Huang W; Pang Y; Ye X; Shi J; Fu L
Front Oncol; 2020; 10():379. PubMed ID: 32266153
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome].
Zhou X; Jin H; Mu Q; Sheng L; Lai B; Zhu H; Ouyang G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):953-956. PubMed ID: 31598934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
